A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

January 27, 2020

Study Completion Date

January 27, 2020

Conditions
Primary Axillary Hyperhidrosis
Interventions
DRUG

Sofpironium Bromide Gel, 5%

Sofpironium Bromide Gel, 5%

DRUG

Sofpironium Bromide Gel, 15%

Sofpironium Bromide Gel, 15%

Trial Locations (12)

33137

Baumann Cosmetic & Research Institute, Miami

33162

Tory Sullivan MD PA, North Miami Beach

33180

Center for Clinical and Cosmetic Research, Aventura

33401

Research Institute of the Southeast, LLC, West Palm Beach

33486

Skin Care Research, Inc., Boca Raton

36608

Coastal Clinical Research, Inc., Mobile

37215

Tennessee Clinical Research Center, Nashville

48088

Grekin Skin Institute, Warren

55432

Minnesota Clinical Study Center, Fridley

72758

Northwest Arkansas Clinical Trials Center, Rogers

77845

J&S Studies, Inc., College Station

78660

Austin Institute for Clinical Research, Pflugerville

Sponsors
All Listed Sponsors
lead

Botanix Pharmaceuticals

INDUSTRY